Canada · Investor

T2C2 Capital

Last cheque observed Oct 2006. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment firm

Series BVentureSeries A

Cheques on record
0%of best year0cheques in 12 months, 9 on record
Since the last cheque7306days00hrs00min00sec
Median round$12MRounds led0 of 9Exits3 from the portfolioMostly inCanada, 78%
Pitch T2C2 Capital

T2C2 Capital highlights

  1. 01

    9 rounds on record

  2. 02

    Mostly Series B and Venture: 89% of its rounds

  3. 03

    3 exits from the portfolio

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Based in
Canada
Cold pitches
Not stated

The record

Every round we can evidence, newest first9 appearances

  1. 2006

    1 round

  2. Oct
    CytherisSeries B · FR · cytheris.com$31MWith 7 others
  3. 2005

    3 rounds

  4. Oct
    Topigen PharmaceuticalsSeries B · CA$5.1MWith 5 others
  5. May
    BioAxone TherapeuticSeries B · CA · biospace.com$12MWith 3 others
  6. Jan
    Enobia PharmaSeries A · CA · researchviews.com$16MWith 3 others
  7. 2004

    1 round

  8. Dec
    Topigen PharmaceuticalsVenture · CA$19MWith 4 others
  9. 2003

    2 rounds

  10. Nov
    ChronogenSeries B · CA$13MWith 3 others
  11. Nov
    IatroQuest CorporationVenture · CA$11MWith 3 others
  12. 2001

    2 rounds

  13. Dec
    CytochromaVenture · US$2.2MWith 3 others
  14. Oct
    Interomex BioPharmaceuticalsSeries B · CA$4.0MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

CytochromaBought by OPKO HealthUndisclosedJan 2013
Enobia PharmaBought by Alexion PharmaceuticalsUndisclosedDec 2011
Topigen PharmaceuticalsBought by PharmaxisUndisclosedJan 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as T2C2 Capital. A count of rooms they were both in, not a relationship either has claimed.

BDC CapitalVC firm6rounds togetherDesjardins Venture CapitalGovernment6rounds togetherFonds de solidarite FtqVC firm5rounds togetherCaisse de Depot et Placement du QuebecInstitutional LP2rounds togetherInnovatech Grand MontrealVC firm2rounds together

Quick answers about T2C2 Capital

What does T2C2 Capital invest in?

T2C2 Capital invests most often at Series B and Venture (89% of the rounds on record).

How active is T2C2 Capital?

9 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2006.

How big are T2C2 Capital's cheques?

The median round it joins is $12M.

Does T2C2 Capital lead rounds?

Rarely, if at all: none of its 9 investments on record names it as the lead.

Where does T2C2 Capital invest?

Most of the companies it backs are in Canada (78%), France (11%) and the United States (11%).

Is T2C2 Capital investing now?

No investments in the last 12 months; the latest was in Oct 2006.

Who does T2C2 Capital invest alongside?

Most often BDC Capital (6 rounds together), Desjardins Venture Capital (6 rounds together) and Fonds de solidarite Ftq (5 rounds together).

What kind of investor is T2C2 Capital?

T2C2 Capital is an investment firm based in Canada.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it